July 6, 2017
San Francisco-based Mendel.ai, a startup that is developing an artificial intelligence-powered platform to match people with cancer to clinical trials, has raised $2 million in seed funding from DCM Ventures, BootstrapLabs, Indie Bio, LaunchCapital and SOSV. Medel.ai will use the capital to forge partnerships with hospitals and cancer genomics companies to bring the system into use.
April 27, 2017
New York-based Fit4D, which offers digital coaching for people with diabetes, is partnering with global diabetes data management company Glooko to bring a more data-driven approach to their mobile patient engagement tools. The pairing will give Fit4D’s coaches access to Glooko’s device-agnostic platform, which people with diabetes see in the form of a mobile app they can use to automatically sync...
April 24, 2017
Medidata, a New York City-based company that offers cloud storage and data analytics services for clinical trials, announced last week its plans to acquire Mytrus, a clinical trial technology company focused on patient-focused electronic informed consent and remote trials. The terms of the acquisition were not disclosed.
“The informed consent process is one of the most important parts of running...
October 19, 2016
IBM has partnered with Quest Diagnostics to launch a new precision medicine service that blends cognitive computing with genomic tumor sequencing. The service, IBM Watson Genomics from Quest Diagnostics, allows a physician to send a tissue sample to Quest, which will sequence the tumor DNA and send the genetic data through Watson for analysis. Watson runs through its reposititory of literature,...
September 23, 2016
When Apple announced ResearchKit in March 2015, and unveiled the first five apps to test-drive the company’s new approach to clinical research, the announcement made a big splash. And indeed, in the weeks following, those apps posted incredible recruitment figures: for instance, Parkinson’s emPower study saw 5,500 sign-ups by day two and ended up with more than 18,000 participants.
July 21, 2016
Memorial Sloan Kettering Cancer Center is working with Medidata to launch a small patient-generated health data trial of 40 patients with multiple myeloma, a blood cancer that accumulates in the bone marrow. Patients in the trial will track their activity and sleep with wearable devices and use an app to answer survey questions about quality of life measures like fatigue and appetite.
November 17, 2014
Pharmaceutical company GlaxoSmithKline is using mobile health tools in a small study -- just six subjects -- that could lead to there more widespread use in clinical trials. The company is working with data startup Medidata and sensor makers Vital Connect and ActiGraph to evaluate the impact of wearable sensors in clinical trial settings.
“Working with GSK on this initiative has provided us with...
November 1, 2013
Clinical Ink, a pharma-focused mobile clinical trial data collection company, has raised $4.3 million. FCA Venture partners led the round, with additional funding from 10 undisclosed angel investors.
Clinical Ink makes SureSource, a windows-based tablet software for healthcare providers to collect clinical trial data electronically at the point of care. They use Windows tablets because stylus...